Mask Protective Clothing Is Too Hot! In The Same Period Last Year, Only 60 Million Of Zhen De Medical Earned 900 Million Over The First Half Of The Year.

Zhen de medical supplies Limited by Share Ltd (hereinafter referred to as "Zhen de medical") released the first half of 2020 performance forecast in July 7th. It is estimated that the operating income of the company will reach 3 billion 738 million yuan to 3 billion 938 million yuan during the reporting period. It increased by 2 billion 976 million yuan to 3 billion 176 million yuan over the same period last year. The net profit attributable to the parent company will increase by 925 million -9.55 billion compared with the same period last year, compared with 60 million 105 thousand yuan in the same period last year.

For the main reason for the growth of performance, Zhen de medical explanation said:

(1) during the reporting period, the sales of the company's epidemic prevention products reached 2 billion 600 million yuan to 2 billion 720 million yuan, an increase of 2 billion 566 million yuan to 2 billion 686 million yuan over the same period last year.

(2) during the reporting period, the sales revenue after the elimination of epidemic protection products was 1 billion 120 million yuan to 1 billion 200 million yuan, an increase of 399 million yuan to 479 million yuan over the same period last year, an increase of 55% to 66% over the same period last year.

2, the large scale production and operation advantages and the continuous improvement of supply chain capabilities brought about by the large scale of business scale have promoted the overall gross profit margin of Zhen de medical care.

According to public information, Zhen de medical was established in 1994, specializing in the production and sale of medical dressings. The export revenue ranks the top three in the industry. The production plant of the company is located in Shaoxing, Zhejiang, Hangzhou, Henan Xuchang, Anhui Huainan, Jiangsu Suzhou and Xinjiang Alashankou. The main business of the company is the production, research and development and sale of medical dressings. The main products are modern. There are four kinds of wound dressing, surgical sense control products, traditional wound care products, and pressure treatment and fixed products.

Up to now, Zhen de medical has become a leading manufacturer of medical dressings in China. The company started with exports, and for many years lived in the top three of China's medical dressing exports.

China gold company analyst Fang duo said that Zhen de medical has cotton yarn and non-woven fabrics and other raw materials production line (Alashankou Zhen De), part of the cotton yarn for sale abroad. Downstream docking domestic hospitals / pharmacies and overseas medical device brands, has a certain brand effect in the country, gross margin is higher than overseas business.

According to the financial report, in 2019, the revenue of Zhen de medical treatment reached 1 billion 867 million yuan, an increase of 30.71% over the same period last year, and the net profit attributable to the parent company was 156 million yuan, an increase of 20.50% over the same period last year. According to the subregional perspective, domestic sales of 598 million yuan, an increase of 33.28% over the same period last year (excluding cotton yarn, special custom equipment and other sales revenue) increased by 39.58% over the same period last year, including online sales exceeding 18 million yuan, a 87.37% increase over the same period last year, and a 1 billion 257 million 309 thousand and 300 yuan increase in environmental sales, representing a 29.82% increase over the same period last year.

In the first quarter of 2020, the total revenue of Zhen de medical business was 710 million, an increase of 112.3% over the same period last year, and net profit of 85 million 913 thousand, an increase of 180.6% compared with the same period last year. The earnings per share were 0.61 yuan. During the reporting period, the gross profit margin of the company was 42.1%, an increase of 13 percentage points over the same period, and the net interest rate was 12.2%, an increase of 2.9 percentage points over the same period last year.

Fang duo believes that Zhen de medical has certain competitiveness in the field of domestic products and channel promotion, and the development trend is good. In the future, domestic sales business is expected to replace exports as the main driving force of performance.